Dr Arron Tolley

Chief Executive Officer

Arron is the founder and Chief Executive Officer of Aptamer Group. Arron holds a Ph.D. in Molecular Biology and Biophysics from the University of Leeds and a B.Sc. in Molecular Medicine. Arron has over 20 years’ experience in the field of nucleic acid biology and has expertise in the development of aptamers against multiple target types, including complex cellular targets in model disease systems. He led the growth of the company from a small laboratory built in the basement of his house to a successful aptamer development company.  Arron has led the business through various stages of growth, and funding, including the AIM IPO in December 2021. Arron has extensive experience in business development, business administration and translational science and holds an honorary professorship for translational science and entrepreneurship from the University of Surrey.